LONDON (Alliance News) -<strong> British Sky Broadcasting</strong> confirmed Monday that it is working on the potential acquisition of 21st Century Fox's interests in Sky Deutschland and Sky Italia.<br /><br />Bloomberg, citing people familiar with the matter, reported that talks about the pot Read More
LONDON (Alliance News) - US drugmaker Pfizer Inc continued its campaign to buy FTSE 100 drugmaker AstraZeneca PLC Monday, submitting a statement to the UK House of Commons. Pfizer's Chief Executive Ian Read and AstraZeneca's Chief Executive Pascal Soriot will present evidence to the House B Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>British Sky Broadcasting</strong> Group PLC confirmed it is working on the potential acquisition of 21st Century Fox's interests in Sky D Read More
LONDON (Alliance News) - UK shares have opened cautiously higher Monday, amid a lack of economic data and with a wary eye on developments in Ukraine.<br /><br /><strong>BSkyB</strong> confirmed press reports that has approached its major shareholder 21st Century Fox about buying Sky Deutschlan Read More
LONDON (Alliance News) - AstraZeneca PLC and Amgen Inc said Monday that the Phase 3 AMAGINE-1 study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and secondary endpoints for both evaluated doses. Brodalumab is the only investigational treatment i Read More
LONDON (Alliance News) - AstraZeneca PLC and Amgen Inc said Monday that the Phase 3 AMAGINE-1 study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and secondary endpoints for both evaluated doses. Brodalumab is the only investigational treatment i Read More
LONDON (Alliance News) - AstraZeneca PLC and Amgen Inc said Monday that the Phase 3 AMAGINE-1 study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and secondary endpoints for both evaluated doses. Brodalumab is the only investigational treatment i Read More
LONDON (Alliance News) - Pfizer Inc.'s Chief Executive Officer Ian Read said that the company's proposed takeover of British drug maker AstraZeneca PLC would be a "win-win" for society and shareholders. In a series of videos posted on Pfizer's website, Ian Read said that the deal would libe Read More
LONDON (Alliance News) - Pfizer Inc.'s Chief Executive Officer Ian Read said that the company's proposed takeover of British drug maker AstraZeneca PLC would be a "win-win" for society and shareholders. In a series of videos posted on Pfizer's website, Ian Read said that the deal would libe Read More
LONDON (Alliance News) - Oil and gas services company<strong> Petrofac</strong> Friday issued a profit warning after it said the planned development of the Greater Stella Area oil field in the North Sea would be delayed until next spring, it was hit by low output at a Romanian oil field, and w Read More
LONDON (Alliance News) - Shareholders in Viagra maker Pfizer Inc could take a tax hit if its proposed takeover of UK pharmaceutical giant AstraZeneca goes through, the Wall Street Journal reported, as it separately emerged a key British medical research body had written to the UK government sayin Read More
LONDON (Alliance News) - British gas parent <strong>Centrica</strong> has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians Read More
LONDON (Alliance News) - AstraZeneca PLC said Thursday that it had initiated its Phase III immunotherapy study for the compound MEDI4736 for the treatment of non-small cell lung cancer. The study will assess progression-free survival and the overall survival rate of patients treated with th Read More
LONDON (Alliance News) - US drugs giant Pfizer IncWednesday further detailed its case for combining its business with AstraZeneca PLC, after the UK drugsmaker Tuesday called for shareholders to be patient as it set out growth plans for the coming three years. Pfizer said Wednesday that with Read More
LONDON (Alliance News) - The FTSE 100 lost ground Tuesday, snapping a five day winning streak as investors returned from a long weekend, over which the conflict in Ukraine continued to escalate, to some disappointing corporate news from the likes of <strong>Barclays</strong> and <strong>Balfou Read More
LONDON (Alliance News) - <strong>AstraZeneca</strong> Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly after it invests in its pipeline and transforms the company over the next few Read More
LONDON (Alliance News) - British drugs company AstraZeneca PLC Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly once it has invested in its pipeline and transformed the company over th Read More
LONDON (Alliance News) - British drugs company AstraZeneca PLC Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly after it invests in its piepline and transforms the company over the nex Read More
LONDON (Alliance News) - The following is a summary of top news stories Tuesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />British drugs company<strong> AstraZeneca</strong> PLC set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urgi Read More
(Correcting AstraZeneca made its statement on Tuesday.) LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Persimmon</strong>, up 3 Read More